In this study, we characterized PDA infiltrating hematopoietic cells and determined the expression of PD‐L1 and HLA by PDA tumor cells to determine the immunological status of the PDA TME, its immune escape systems, and the impact of these factors on the patients’ prognosis. The gene discussed is CD274; the disease is Patent ductus arteriosus.